Meeting
2023 ASCO Annual Meeting
Artificial intelligence (AI) –powered spatial analysis of macrophages in tumor microenvironment and its association with interferon-gamma (IFNG) signature and immune phenotype (IP) in pan-cancer dataset.
Authors
Chiyoon Oum
Lunit Inc., Seoul, South Korea
Chiyoon Oum , Gahee Park , Heon Song , Jinhee Lee , Sergio Pereira , Sanghoon Song , Sukjun Kim , Wonkyung Jung , Chan-Young Ock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2621)
DOI
10.1200/JCO.2023.41.16_suppl.2621
Abstract #
2621
Poster Bd #
463
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D+/-T) in head and neck squamous cell carcinoma (HNSCC).
First Author: Hyunwook Kim
Poster
2023 ASCO Annual Meeting
Spatial genomics to reveal an immunosuppressive tumor microenvironment after chemoradiation in head and neck cancer patients.
First Author: Jennifer Hsing Choe
Poster
2023 ASCO Annual Meeting
Relationship between tumor microenvironment (TME)-based histomic TGFβ signature (TGFBs), stromal fibroblast recruitment, and exclusion of immune cells as immunotherapy resistance mechanisms.
First Author: Gahee Park
Poster
2022 ASCO Annual Meeting
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach.
First Author: Marie Cumberbatch